ABEONA THERAPEUTICS INC. (ticker: ABEO) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of ABEO's SEC filings surfaces 4 active risk signals, including 2 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. ABEO reported $8.72M in revenue and -$17.07M for the period ending 2026-03-31, with operating cash flow of -$19.80M. Cash and equivalents stood at $61.37M (up 285.1% year-over-year). Total assets of $198.49M exceed total liabilities of $53.55M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
ABEO SEC Filings
Full cached SEC EDGAR filing history for ABEO, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.